VSee Health, Inc.

VSEE Healthcare Health Information Services

VSee Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.6 million, up 40.3% from fiscal 2024.

Revenue
−53.9%
EPS
+109.9%
Free cash flow
−257.6%
Total debt
+31.6%

Quarter to June 2026, against a year earlier

1.00 0.15 −13.04%
Market cap
$2.8M
P/E
0.0×
Fwd P/E
−2.2×
Dividend yield
—
F-score
4/9
Altman Z
−6.06
Beneish M
−4.22
Dividend safety
n/a

Insider Decisions last twelve months

Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 0.00%

Capital & Financial Ratios $m

Size
Market Cap 2.80
Revenue ttm 12.63
Net income ttm (9.89)
Free cash flow ttm (6.31)
Net debt Q 0.33
Valuation
P/E 0.00
Forward P/E (2.17) (negative: loss-making)
Price / sales 0.06
Forward P/S Powerpack
Price / FCF 0.00
Price / book 0.10
Financial health
Current ratio Q 0.40 (below 1: weak)
Debt / equity Q 0.10 (at or below 0.5: strong)
Interest coverage Q (33.42)
Growth
Revenue growth Q −53.93% (below 0%: shrinking)
Operating income growth Q −73.34% (below 0%: shrinking)
EPS, this year −1,100.00% (below 0%: weak)
EPS, next year A +33.33% (at or above 15%: strong)
Revenue, next year A +47.83% (at or above 10%: strong)
EPS, past 5 yrs —
EPS, next 5 yrs A —

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 0 0 5 0
Receivables 1 2 3 2
Inventory — — — —
Other — 1 0 0
1 3 8 3
2023 2024 2025 Q'26
Payables 3 9 12 6
ST’ Debt — — — —
Other 1 0 1 0
5 19 16 8

Compound Annual Growth %

10y 5y 3y
Sales — — —
Cash Flow — — 0.00%
Earnings — — 0.00%
Book Value — — 0.00%

EPS $

Mar Jun Sep Dec Year
’26 (4.34) 0.62 — — —
’25 (19.42) (6.37) (1.40) (31.25) (58.43)
’24 1.08 (10.05) (286.10) (16.21) (451.99)
’23 (36.36) (7.39) (0.89) — (29.81)
’22 (2.83) (3.53) (4.40) (9.60) (20.36)
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 3 2 — — —
’25 3 3 4 4 15
’24 2 2 3 4 10
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (2) (1) — — —
’25 0 0 (1) (2) (3)
’24 1 (3) 0 (3) (6)
’23 0 0 0 0 (1)
’22 0 0 0 (1) (1)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (2) (1) — — —
’25 0 0 (1) (2) (3)
’24 1 (3) 0 (3) (6)
’23 0 0 0 0 (1)
’22 0 0 0 (1) (1)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue — — — — — — — 6 10 15 13 +59.2% 22 — — +47.8%
Gross margin, % — — — — — — — 66.47 68.87 50.32 49.77 (16.1) pt
EBT — — — — — 0 (3) (2) (59) (15) (14) +168.8%
EBT margin, % — — — — — 0.00 0.00 (32.73) (569.45) (100.18) (114.59) (100.2) pt
Net income — 0 — — — 0 (3) (4) (58) (15) (10) n/m
Per share, $
Per share, $ Revenue — — — — — 0.00 0.00 46.13 81.61 58.05 18.83 n/m
Earnings — — — — — (5.64) (20.36) (29.81) (451.99) (58.43) (36.36) +79.4%
Cash flow — — — — — (12.05) (8.73) (5.06) (45.34) (13.68) (9.40) +3.2%
Capex — — — — — 0.00 0.00 (0.03) (0.43) (0.12) 0.00 n/m
Free cash flow — — — — — (12.05) (8.73) (5.10) (45.77) (13.80) (9.40) +3.5%
Book value — — — — — (66.96) (46.62) (34.40) (0.14) 21.65 11.32 n/m
Shares, m — — — — — 0 0 0 0 0 0 +50.0%
Valuation, ×
Valuation, × P/E — — — — — — — 0.00 0.00 0.00 0.00 0.0
P/S — — — — — — — 0.00 1.33 0.52 0.06 0.6
P/B — — — — — — — 0.00 0.00 1.38 0.10 0.5
EV/Sales — — — — — — — 0.00 1.36 0.21 0.09 0.5
EV/FCF — — — — — — — (191.37) (2.42) (0.88) (0.17) (64.9)
Cash, $m
Cash, $m Operating cash flow — — — — — (1) (1) (1) (6) (3) (6) +54.8%
Capex — — — — — — — 0 0 0 0 +163.7%
Free cash flow — — — — — (1) (1) (1) (6) (3) (6) +55.1%
Balance, $m
Balance, $m Working capital — — — — — 1 (3) (4) (16) (8) (5) n/m
Net debt — — — — — (1) 0 0 0 (5) 0 +57.5%
Shareholders’ equity — — — — — (3) (7) (4) 0 5 8 n/m
Returns, %
Returns, % ROA — — — — — (0.48) (5.16) (89.17) (554.87) (69.39) (56.62) (68.9) pt
ROIC — — — — — 0.00 0.00 0.00 (15,581.33) (767.86) (93.65) (767.9) pt
ROE — — — — — 0.00 60.26 64.18 2,672.63 (541.52) (1,065.78) (541.5) pt
People
People Employees — — — — — 2 2 2 154 209 — +219.7%
Revenue/emp, $m — — — — — 0.00 0.00 2.88 0.07 0.07 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 2 Nov 2026

VSee Health, Inc. vs peers in Health Information Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
HLTHQ Cue Health Inc. $6.9M — (loss-making) — (loss-making) −87.19% (below 0%: shrinking) n/m +50.55% (above 0%: growing) (90.14%) (792.13%) Compare
ACON Aclarion, Inc. $4.5M — (loss-making) — (loss-making) +78.48% (above 0%: growing) n/m −74.22% (below 0%: shrinking) 43.86% (8,164.70%) Compare
MGRX Mangoceuticals, Inc. $4.3M — (loss-making) — −59.07% (below 0%: shrinking) n/m +79.27% (above 0%: growing) 64.24% (1,501.45%) Compare
ZCMD Zhongchao Inc. $4.3M — (loss-making) — +20.44% (above 0%: growing) −550.00% (below 0%: shrinking) +191.85% (above 0%: growing) 41.67% 0.00% Compare
HCTI Healthcare Triangle, Inc. $3.2M 0.0× — (loss-making) +158.38% (above 0%: growing) n/m +67.48% (above 0%: growing) 22.48% (44.28%) Compare
VSEE VSee Health, Inc. $2.8M — (loss-making) — (loss-making) −53.93% (below 0%: shrinking) n/m −257.62% (below 0%: shrinking) 13.20% (172.69%)
WORX SCWorx Corp. $2.0M — (loss-making) — (loss-making) +3.43% (above 0%: growing) n/m +87.99% (above 0%: growing) 46.80% (17.14%) Compare
MSPR MSP Recovery, Inc. $1.5M — (loss-making) — −94.60% (below 0%: shrinking) n/m +60.88% (above 0%: growing) (26.77%) (62,501.52%) Compare
MNDR Mobile-health Network Solutions $1.1M — — — — — — — Compare
Median of peers $3.7M — — +3.43% — +67.48% 41.67% (792.13%)

All 44 Health Information Services stocks →

Pay and ownership Proxy statement filed 20 July 2026

Ownership

Directors and executive officers, together 14.87%
Armistice Capital, LLC 9.99%
Imoigele Aisiku 9.66%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

VSee Health, Inc. (VSEE) Latest News

27 Aug

Impact 3 ·

10 Mar

12 Dec

Impact 3 · · ACCESS NewswireGuruFocus.comMT NewswiresZacksGuruFocus.comGuruFocus.comZacksMotley Fool

31 Oct

Impact 4 · · ACCESS Newswire

29 Oct

Impact 3 · · Associated Press Finance

28 Oct

Impact 3 ·
stockrow.com/VSEE · Data as of Nov 2, 2026 · For information only; not investment advice. · © 2026 stockrow.com